DE60128367D1 - Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren - Google Patents

Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren

Info

Publication number
DE60128367D1
DE60128367D1 DE60128367T DE60128367T DE60128367D1 DE 60128367 D1 DE60128367 D1 DE 60128367D1 DE 60128367 T DE60128367 T DE 60128367T DE 60128367 T DE60128367 T DE 60128367T DE 60128367 D1 DE60128367 D1 DE 60128367D1
Authority
DE
Germany
Prior art keywords
production
protease inhibitors
intermediate products
retroviral protease
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60128367T
Other languages
English (en)
Other versions
DE60128367T2 (de
Inventor
Sanjay R Chemburkar
Ketan M Patel
Harry O Spiwek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24614772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60128367(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE60128367D1 publication Critical patent/DE60128367D1/de
Application granted granted Critical
Publication of DE60128367T2 publication Critical patent/DE60128367T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DE60128367T 2000-08-31 2001-08-29 Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren Expired - Lifetime DE60128367T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65191900A 2000-08-31 2000-08-31
US651919 2000-08-31
PCT/US2001/026898 WO2002018349A2 (en) 2000-08-31 2001-08-29 Process and intermediates for preparing retroviral protease inhibitors

Publications (2)

Publication Number Publication Date
DE60128367D1 true DE60128367D1 (de) 2007-06-21
DE60128367T2 DE60128367T2 (de) 2008-01-10

Family

ID=24614772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60128367T Expired - Lifetime DE60128367T2 (de) 2000-08-31 2001-08-29 Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren

Country Status (17)

Country Link
EP (1) EP1313712B1 (de)
JP (1) JP5021141B2 (de)
KR (1) KR100806533B1 (de)
CN (1) CN1264823C (de)
AT (1) ATE361913T1 (de)
AU (1) AU2001286889A1 (de)
BR (1) BR0108146A (de)
CA (2) CA2416955C (de)
CY (1) CY1106738T1 (de)
DE (1) DE60128367T2 (de)
DK (1) DK1313712T3 (de)
ES (1) ES2284684T3 (de)
HK (1) HK1057040A1 (de)
IL (1) IL153436A0 (de)
MX (1) MXPA03001751A (de)
PT (1) PT1313712E (de)
WO (1) WO2002018349A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2378669T3 (es) * 2003-12-11 2012-04-16 Abbott Laboratories Compuestos inhibidores de proteasa de VIH
CN100358521C (zh) * 2004-12-28 2008-01-02 哈尔滨欧替药业股份有限公司 一种双唑泰栓剂及其制备工艺
CN103910634B (zh) * 2012-12-29 2018-04-27 广东东阳光药业有限公司 西格列汀中间体的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds

Also Published As

Publication number Publication date
CN1264823C (zh) 2006-07-19
AU2001286889A1 (en) 2002-03-13
JP5021141B2 (ja) 2012-09-05
KR100806533B1 (ko) 2008-02-25
HK1057040A1 (en) 2004-03-12
DK1313712T3 (da) 2007-09-10
CA2731273A1 (en) 2002-03-07
ES2284684T3 (es) 2007-11-16
CA2416955C (en) 2011-04-26
CY1106738T1 (el) 2012-05-23
KR20030061787A (ko) 2003-07-22
EP1313712B1 (de) 2007-05-09
DE60128367T2 (de) 2008-01-10
CA2731273C (en) 2013-10-15
CA2416955A1 (en) 2002-03-07
WO2002018349A3 (en) 2002-05-10
EP1313712A2 (de) 2003-05-28
WO2002018349A2 (en) 2002-03-07
IL153436A0 (en) 2003-07-06
MXPA03001751A (es) 2003-09-10
ATE361913T1 (de) 2007-06-15
CN1449388A (zh) 2003-10-15
JP2004507528A (ja) 2004-03-11
BR0108146A (pt) 2004-01-06
PT1313712E (pt) 2007-07-25

Similar Documents

Publication Publication Date Title
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
BR0215405A (pt) Composições e processos de uso de collajolie
ATE282607T1 (de) Tryptase-inhibitoren
BRPI0312521B8 (pt) método para a separação de fibrinogênio de plasminogênio
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
DE69614824T2 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE60327936D1 (de) Modulatoren von ship-1
AR047756A1 (es) Composicion liquida biologicamente estable de fviii, de fvw o del complejo fviii/fvw humanos
DE60322852D1 (de) Verfahren zur herstellung von eplerenon
WO2004046293A8 (en) Amphoteric fluorescent whitening agents
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
DK0941975T3 (da) Injiceringscement indeholdende korrosionshæmmere
BR9808923B1 (pt) processos para fazer compostos inibidores de ciclooxigenase-2, e, compostos intermediÁrios para fazer inibidores de ciclooxigenase-2.
DE60128367D1 (de) Verfahren und zwischenprodukte zur herstellung von retroviralen proteaseinhibitoren
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
DE60325390D1 (de) Verfahren zur herstellung von zwischenprodukten
SE9800865D0 (sv) New Process
ATE327987T1 (de) Methylthiophencarboxanilide
DE69922999D1 (de) Verfahren zur herstellung von polyhalogenierten para-trifluoroanilinen
DE60329325D1 (de) Synthese von (r) und (s)-aminocarnitin und derivaten davon ausgehend von d-und l-asparaginsäure
DE19881631T1 (de) Verfahren zur Reinigung von Tetrahydrofuranen, die als Ausgangsmaterial für Polyetherpolyole verwendet werden
DE602006008751D1 (de) Synthese von proteaseinhibitorvorstufen
DE50312447D1 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
DE10295581D2 (de) Verfahren zur Synthese von All-D-Peptiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition